Professional linguistic support for medical and pharmaceutical business

MedTranslate was founded in 2011 to, over time, become one of the market's leading providers of medical and pharmaceutical translation services. Today, we maintain our top position in the industry, encouraging long-term cooperation with large-scale companies in Russia, Kazakhstan and beyond. MedTranslate is a partner of ELIA (the European Language Industry Association), and uses state-of-the-art translation software in its work. We have successfully been running our registered offices in major cities in Russia (Moscow) and Kazakhstan (Almaty).

Our achievements

  • A total of over 1,742,400,560 characters have been translated for the entire period of the company's operation.
  • Over 57,000 pages of medical texts per year.
  • We work in the CIS, Far East and European language pairs. A total of 30 + languages.
  • Currently, the company employs over 148 translators and 13 editors.
  • We are members of + 3 Associations (ELIA, Union of Translators of Russia, Association of Translators, Interpreters, and Translation Companies)
  • We use + 4 specialized translation software products
  • We attend +10 field-specific events, exhibitions per year
  • + 40 new loyal clients every single year
  • Clients return for more services in 90% cases
  • We partner with the medical and pharmaceutical market leaders

Focused expertise

12 years' professional experience in narrow-focus translation in the area of medicine and pharmaceuticals industry. MedTranslate's primary goal is to help your business grow!


  • Proper, expertise-specific, choice of translators: medical equipment, clinical trials, tests or diagnostics results.
  • Appropriate and accurate medical terminology.

Operational efficiency

We provide feedback within 15 minutes. Your documents will be translated in the shortest time possible with due account of your specific preferences and requirements.

In-depth analysis of documents

Each document is analyzed end-to-end, which is beyond mere calculation of the number of pages, the amount payable and the service period. As medical companies often translate instructions for use of several models of the same equipment, we also exercise a word-by-word analysis of documents, searching customer orders archive, document-to-document matching, which offers our clients a savings advantage due to similar contents of documents.


  • Efficiently organized translation process supported by competent client managers. We perform tasks from A to Z.
  • A dedicated manager is appointed for each partner.


All the information that we obtain remains within MedTranslate boundaries.

Key Focus Areas:

  • Translation
  • Interpretation
  • Editing/Proofreading
  • Equipment for simultaneous interpretation (for rent)
  • Notarization
  • Rental of equipment for synchronous interpretation


Lidings provides legal advice to Russian and international companies with different industrial background in Russia and CIS.

We have extensive experience in Life Sciences sector advising leading pharmaceutical and healthcare sector companies on comprehensive legal advice and counseling in respect to transactions, interaction with state authorities, contractual work, tax and antitrust regulation, intellectual property protection, compliance and personal data, representing interests in disputes with distributors, processing complex patent and bankruptcy litigation.

Lidings is annually recognized for its expert industry knowledge by the leading international and Russian legal directories as Chambers and Partners, LMG Life Sciences,, Kommersant.


Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros.

For more information, go to


Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.

For more information, visit


PHARMAGATE – a functional and full outsourcing solution provider for professional services for medical goods and life science industry including pharmaceutical, medical device, food supplements, cosmetic and biotech companies.

We support of all aspects of marketing authorization applications and life cycle of the product in geography:

  • Russia, Kazakhstan, Belarus, Armenia, Kyrgyzstan
  • Ukraine, Moldova, Georgia, Azerbaijan
  • Uzbekistan, Tajikistan, Turkmenistan, Mongolia

Our responsibility

  • Strict compliance with international, local regulatory standards, customer policies
  • Optimal timing
  • Activities of high quality within the required project scope

Our approach

  • Partnership for large and small companies
  • Excellence and lifelong learning
  • Commercial awareness
  • Risk management board
  • Flexibility in projects flow
  • Multilingualism


  • Quality management system
  • ISO certified 9001:2015
  • Customers audited – more than 10
  • Quality certification bodies audited – 8

Services profile & expertise for all types of medical goods – pharmaceutical products, medical devices, food supplements, special food, hygienic products, cosmetics

Consulting for products regulatory & market access strategy

All types of regulatory affairs activities for medical use approvals

Product’s life-cycle management

Pharmacovigilance/safety & quality compliance system maintanance,

local QPPV/safety desk activities

Trainings for industry professionals

Operations from 2011

  • Number of approvals 600+
  • Number of employees 45
  • Countries of operations13
  • Number of partners 50+


Statandocs was founded in 2016 by a group of experts in the field of clinical and preclinical trials. The main goal of the founders of the company at that time was to help the pharmaceutical industry in preparing high-quality clinical and registration dossiers of medicines. Since the beginning of its activity, Statandocs specialists have provided consulting services on the optimal drug development strategy, medical writing services - from concept to protocol and other essential documents of a clinical trial, statistical support from substantiating the sample size to generating a report on the research results, preparing a dossier in a common technical document (CTD) according to the requirements of the local legislation of the Russian Federation and in the CTD format according to the Eurasian Economic Union (EAEU) legislation.


Taking into account the rapid changes in the regulatory environment both at the national and international levels, the company's employees are constantly trained at educational seminars and refresher courses at the FSBI «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, FSBI "VNIIIMT" of Roszdravnadzor, FSBI "National Institute of Quality" of Roszdravnadzor (formerly FSBI CMIKEE of Roszdravnadzor), FSI SID and GP. Effective and most useful work for our customers is impossible without understanding the pressing problems that pharmaceutical companies face on a daily basis, without exchanging experience with colleagues and representatives of the regulator in the process of real-life communication. Therefore, the company line-of-business owners annually participate in key industry conferences and congresses, such as RegLek, PharmMedOverview, Circulation of medical devices, International Congress on Clinical Trials for Medical Devices (CTMD), the Adam Smith Institute International Forum "Clinical Research in Russia", the Asian Pharmaceutical Forum , and for the last two years as invited speakers and organizers of master classes, invariably arousing the interest of delegates.


The active participation of Statandocs in the life of the industry is directly related to the development of the company and the emergence of new areas of activity. So, with the entry into force of the Rules of Good Pharmacovigilance Practice of the EAEU and the orders of the national regulator based on these rules, since 2017, there has been a growing demand for the preparation of high-quality documents for the pharmacovigilance system: a periodic safety update report (PSUR), a development safety update report (DSUR), a risk management plan (RMP), a pharmacovigilance system master file. Today, the company employees certified specialists in the pharmacovigilance, the documents prepared by them meet the strict requirements of the Roszdravnadzor experts, and in most cases they are accepted without comment from the first filing. Due to a very serious attitude towards information security, the company employees highly qualified specialists in the field of IT technologies. With the participation of experts from the IT department and specialists from the Data management department, we have implemented our own electronic CRF and IWRS services, ensure the development of databases, data entry and validation, the formation of clarifying queries, and the uninterrupted operation of databases containing information on tens of thousands of patients. Statandocs is one of the first companies to offer a service for the preparation of an electronic CTD (eCTD) in accordance with the EAEU requirements. The prepared eCTD have been validated and accepted by the regulatory authorities of the Russian Federation and the Republic of Kazakhstan. In 2019, a service was launched to write the SmPC, the package leaflet and conduct user testing of the package leaflet, in particular, more than 10 user tests were carried out using telecommunications technologies during the period of restrictive measures in connection with the pandemic of the novel coronavirus infection COVID-19.


For 4 years of work, Statandocs employees have completed more than 900 projects. Huge experience has been accumulated in the field of scientific and regulatory medical writing, examination of preclinical and clinical dossiers, including with the preparation of legally significant conclusions; 6 development programs, including the development of original molecules, have been accompanied by us from the first human research to registration. The high qualifications of Statandocs specialists are recognized by experts from the regulatory bodies of the Russian Federation and the EAEU, which is confirmed by the inclusion in the working group that prepares guidelines on the statistical aspects of clinical trials. Leading experts of Statandocs conduct trainings and seminars, as well as webinars in all areas of the company's activities. Our employees took part as invited lecturers in certification educational cycles on the examination and registration of medicines, good clinical practice, organized by the FSBI «Scientific Centre for Expert Evaluation of Medicinal Products» , as well as in the development and conduct of the course "Documents of clinical trials of drugs" on the basis of the I. M. Sechenov first Moscow State Medical University with the issuance of state-recognized certificates.


Matchflow is a smart digital platform for managing marketing and loyalty programs in pharmaceutical retail chains. It allows pharm companies to conduct business in real time, based on up-to-date sales data.

Key features:

  • Online data vs historic retro data. Calculation of lost profits and potential gains
  • Increase ROI up to 20% with marketing campaigns
  • Analysis of the effectiveness of marketing activity
  • Automatic verification of cash checks
  • Focus on working with pharmacies
  • Data security and ethics